Patents by Inventor Susan M. Sheehan

Susan M. Sheehan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endoparasitic depsipeptides
    Patent number: 11786575
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Grant
    Filed: March 17, 2022
    Date of Patent: October 17, 2023
    Assignee: Zoetis Services LLC
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christopher S Knauer, Rajendran Vairagoundar
  • Endoparasitic Depsipeptides
    Publication number: 20220211802
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Application
    Filed: March 17, 2022
    Publication date: July 7, 2022
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christopher S. Knauer, Rajendran Vairagoundar
  • Endoparasitic depsipeptides
    Patent number: 11331369
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 17, 2022
    Assignee: Zoetis Services LLC
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christoper S. Knauer, Rajendran Vairagoundar
  • Endoparasitic Depsipeptides
    Publication number: 20200282016
    Abstract: The present invention provides cyclic depsipeptides of Formula (1), stereoisomers thereof, and veterinary acceptable salts thereof wherein each of R1, R2, R3, R4, L1, and L2, are as defined herein. The present invention also contemplates compositions and methods of treatment as an endoparasiticide with a Formula (1) compound.
    Type: Application
    Filed: November 28, 2018
    Publication date: September 10, 2020
    Inventors: Michael P. Curtis, Susan M. Sheehan, Graham M. Kyne, Matthew W. Bedore, Richard A. Ewin, Paul D. Johnson, Tom L. McTier, Christoper S. Knauer, Rajendran Vairagoundar
  • Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
    Patent number: 7112595
    Abstract: The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
    Type: Grant
    Filed: November 3, 2003
    Date of Patent: September 26, 2006
    Assignees: NPS Pharmaceuticals, Inc., Astrazeneca AB
    Inventors: Bradford Van Wagenen, Thomas M. Stormann, Scott T Moe, Susan M Sheehan, Donald McLeod, Daryl L Smith, Methvin Isaac, Abdelmalik Slassi, Ian Egle, Louise Edwards, Tomislav Stefanac, Tao Xin, Jalaj Arora, William Michne
  • Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
    Patent number: 7053104
    Abstract: The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
    Type: Grant
    Filed: August 5, 2002
    Date of Patent: May 30, 2006
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Bradford C. Van Wagenen, Scott T. Moe, Daryl L. Smith, Susan M. Sheehan, Irina Shcherbakova, Ruth Walton, Richard Trovato, Robert Barmore, Eric G. Delmar, Thomas M. Stormann
  • Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
    Patent number: 6660753
    Abstract: The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: December 9, 2003
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Bradford Van Wagenen, Thomas M. Stormann, Scott T. Moe, Susan M. Sheehan, Donald A. McLeod, Daryl L. Smith, Methvin Benjamin Isaac, Abdelmalik Slassi
  • Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
    Publication number: 20030055085
    Abstract: The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
    Type: Application
    Filed: February 19, 2002
    Publication date: March 20, 2003
    Inventors: Bradford Van Wagenen, Thomas M. Stormann, Scott T. Moe, Susan M. Sheehan, Donald A. McLeod, Daryl L. Smith, Methvin Benjamin Isaac, Abdelmalik Slassi
  • Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
    Publication number: 20030013715
    Abstract: The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
    Type: Application
    Filed: August 5, 2002
    Publication date: January 16, 2003
    Applicant: NPS PHARMACEUTICALS, INC.
    Inventors: Bradford C. Van Wagenen, Scott T. Moe, Daryl L. Smith, Susan M. Sheehan, Irina Shcherbakova, Ruth Walton, Richard Trovato, Robert Barmore, Eric G. Delmar, Thomas M. Stormann
  • Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
    Patent number: 6429207
    Abstract: The present invention provides compounds, and pharmaceutical compositions containing those compounds, that are active at metabotropic glutamate receptors. The compounds are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: August 6, 2002
    Assignee: NPS Pharmaceuticals, Inc.
    Inventors: Bradford C. Van Wagenen, Scott T. Moe, Daryl L. Smith, Susan M. Sheehan, Irina Shcherbakova, Richard Travato, Ruth Walton, Robert Barmore, Eric G. Delmar, Thomas M. Stormann